Kevin C Oboyle - Net Worth and Insider Trading
Kevin C Oboyle Net Worth
The estimated net worth of Kevin C Oboyle is at least $4 Million dollars as of 2024-11-13. Kevin C Oboyle is the Director of GenMark Diagnostics Inc and owns about 103,550 shares of GenMark Diagnostics Inc (GNMK) stock worth over $2 Million. Kevin C Oboyle is the Director of ZELTIQ Aesthetics Inc and owns about 11,985 shares of ZELTIQ Aesthetics Inc (ZLTQ) stock worth over $676,913. Kevin C Oboyle is also the Director of Wright Medical Group NV and owns about 12,390 shares of Wright Medical Group NV (WMGI) stock worth over $371,452. Besides these, Kevin C Oboyle also holds NuVasive Inc (NUVA) , Nevro Corp (NVRO) , Sientra Inc (SIENQ) . Details can be seen in Kevin C Oboyle's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kevin C Oboyle has not made any transactions after 2021-12-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kevin C Oboyle
Kevin C Oboyle Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kevin C Oboyle owns 6 companies in total, including Sientra Inc (SIENQ) , GenMark Diagnostics Inc (GNMK) , and Nevro Corp (NVRO) among others .
Click here to see the complete history of Kevin C Oboyle’s form 4 insider trades.
Insider Ownership Summary of Kevin C Oboyle
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SIENQ | Sientra Inc | 2019-06-07 | director |
GNMK | GenMark Diagnostics Inc | 2020-05-29 | director |
NVRO | Nevro Corp | 2021-12-14 | director |
2019-07-26 | director | ||
2017-04-28 | director | ||
2009-12-15 | VP & Finance and CFO |
Kevin C Oboyle Latest Holdings Summary
Kevin C Oboyle currently owns a total of 6 stocks. Among these stocks, Kevin C Oboyle owns 103,550 shares of GenMark Diagnostics Inc (GNMK) as of March 6, 2020, with a value of $2 Million and a weighting of 66.71%. Kevin C Oboyle owns 11,985 shares of ZELTIQ Aesthetics Inc (ZLTQ) as of September 15, 2016, with a value of $676,913 and a weighting of 18.14%. Kevin C Oboyle also owns 12,390 shares of Wright Medical Group NV (WMGI) as of March 1, 2019, with a value of $371,452 and a weighting of 9.95%. The other 3 stocks NuVasive Inc (NUVA) , Nevro Corp (NVRO) , Sientra Inc (SIENQ) have a combined weighting of 5.2% among all his current holdings.
Latest Holdings of Kevin C Oboyle
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
GNMK | GenMark Diagnostics Inc | 2020-03-06 | 103,550 | 24.04 | 2,489,342 |
ZLTQ | ZELTIQ Aesthetics Inc | 2016-09-15 | 11,985 | 56.48 | 676,913 |
WMGI | Wright Medical Group NV | 2019-03-01 | 12,390 | 29.98 | 371,452 |
NUVA | NuVasive Inc | 2009-12-15 | 3,338 | 39.75 | 132,686 |
NVRO | Nevro Corp | 2021-12-14 | 13,318 | 4.60 | 61,261 |
SIENQ | Sientra Inc | 2019-06-07 | 5,377 | 0.03 | 134 |
Holding Weightings of Kevin C Oboyle
Kevin C Oboyle Form 4 Trading Tracker
According to the SEC Form 4 filings, Kevin C Oboyle has made a total of 1 transactions in GenMark Diagnostics Inc (GNMK) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in GenMark Diagnostics Inc is the acquisition of 10,800 shares on March 6, 2020, which cost Kevin C Oboyle around $48,924.
According to the SEC Form 4 filings, Kevin C Oboyle has made a total of 0 transactions in ZELTIQ Aesthetics Inc (ZLTQ) over the past 5 years. The most-recent trade in ZELTIQ Aesthetics Inc is the sale of 7,500 shares on September 15, 2016, which brought Kevin C Oboyle around $300,600.
According to the SEC Form 4 filings, Kevin C Oboyle has made a total of 0 transactions in Wright Medical Group NV (WMGI) over the past 5 years. The most-recent trade in Wright Medical Group NV is the sale of 6,417 shares on March 1, 2019, which brought Kevin C Oboyle around $205,344.
More details on Kevin C Oboyle's insider transactions can be found in the Insider Trading History of Kevin C Oboyle table.Insider Trading History of Kevin C Oboyle
- 1
Kevin C Oboyle Trading Performance
GuruFocus tracks the stock performance after each of Kevin C Oboyle's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kevin C Oboyle is 35.03%. GuruFocus also compares Kevin C Oboyle's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kevin C Oboyle within 3 months outperforms 5 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kevin C Oboyle's insider trading performs compared to the benchmark.
Performance of Kevin C Oboyle
Kevin C Oboyle Ownership Network
Ownership Network List of Kevin C Oboyle
Ownership Network Relation of Kevin C Oboyle
Kevin C Oboyle Owned Company Details
What does Sientra Inc do?
Who are the key executives at Sientra Inc?
Kevin C Oboyle is the director of Sientra Inc. Other key executives at Sientra Inc include director & President and CEO Ronald Menezes , General Counsel and VP Oliver Christian Bennett , and Chief Financial Officer Andrew C Schmidt .
Sientra Inc (SIENQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sientra Inc (SIENQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sientra Inc (SIENQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sientra Inc (SIENQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sientra Inc Insider Transactions
Kevin C Oboyle Mailing Address
Above is the net worth, insider trading, and ownership report for Kevin C Oboyle. You might contact Kevin C Oboyle via mailing address: 5964 La Place Court, Carlsbad Ca 92008.